Table 3.
Pain intensity score (dysmenorrhea, dyspareunia, and chronic pelvis pain) before and after treatment in the vitamin C/E group.
| Pain | Before | Week 2 | Week 4 | Week 6 | Week 8 | Repeated measures ANOVA | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | SD | M | SD | M | SD | M | SD | M | SD | ||
| Vitamin C/E group | |||||||||||
| Dysmenorrhea | 50.53 | 32.12 | 32.13 | 24.39 | 26.1 | 21.2 | 19.66 | 18.03 | 17.56 | 65/16 | F = 40.5, p < 0.001 |
| Dyspareunia | 66.26 | 28.27 | 23.83 | 25.88 | 20.9 | 23.45 | 17.96 | 20.5 | 15.43 | 18.47 | F = 9.7, p < 0.001 |
| Chronic pelvic pain | 66.26 | 27.84 | 26.7 | 28.17 | 22.06 | 22.83 | 17 | 17.93 | 12.43 | 13.28 | F = 18.57, p < 0.001 |
|
| |||||||||||
| Placebo group | |||||||||||
| Dysmenorrhea | 51 | 34.21 | 35.5 | 28.47 | 34.46 | 27.9 | 32.33 | 27.12 | 31.56 | 26.39 | F = 41.39, p < 0.001 |
| Dyspareunia | 20.73 | 21.77 | 20.66 | 21.74 | 18.8 | 20.11 | 18.4 | 19.91 | 18.1 | 19.93 | F = 5.87, p < 0.001 |
| Chronic pelvic pain | 16.96 | 16.28 | 16.76 | 18.36 | 18.1 | 17.8 | 18 | 18.19 | 18.63 | 18.35 | F = 0.73, p=0.571 |
M, mean; SD, standard deviation.